Author
Listed:
- Tongqing Li
(Yale University School of Medicine
Yale University)
- Steven E. Stayrook
(Yale University School of Medicine
Yale University)
- Yuko Tsutsui
(Yale University School of Medicine
Yale University)
- Jianan Zhang
(Yale University School of Medicine
Yale University)
- Yueyue Wang
(Yale University)
- Hengyi Li
(Yale University School of Medicine
Yale University)
- Andrew Proffitt
(Celldex Therapeutics)
- Stefan G. Krimmer
(Yale University School of Medicine)
- Mansoor Ahmed
(Yale University School of Medicine)
- Olivia Belliveau
(Yale University)
- Ian X. Walker
(Yale University School of Medicine
Yale University)
- Krishna C. Mudumbi
(Yale University School of Medicine
Yale University)
- Yoshihisa Suzuki
(Yale University School of Medicine)
- Irit Lax
(Yale University School of Medicine
Yale University)
- Diego Alvarado
(Celldex Therapeutics)
- Mark A. Lemmon
(Yale University School of Medicine
Yale University)
- Joseph Schlessinger
(Yale University School of Medicine
Yale University)
- Daryl E. Klein
(Yale University School of Medicine
Yale University)
Abstract
The proto-oncogene ALK encodes anaplastic lymphoma kinase, a receptor tyrosine kinase that is expressed primarily in the developing nervous system. After development, ALK activity is associated with learning and memory1 and controls energy expenditure, and inhibition of ALK can prevent diet-induced obesity2. Aberrant ALK signalling causes numerous cancers3. In particular, full-length ALK is an important driver in paediatric neuroblastoma4,5, in which it is either mutated6 or activated by ligand7. Here we report crystal structures of the extracellular glycine-rich domain (GRD) of ALK, which regulates receptor activity by binding to activating peptides8,9. Fusing the ALK GRD to its ligand enabled us to capture a dimeric receptor complex that reveals how ALK responds to its regulatory ligands. We show that repetitive glycines in the GRD form rigid helices that separate the major ligand-binding site from a distal polyglycine extension loop (PXL) that mediates ALK dimerization. The PXL of one receptor acts as a sensor for the complex by interacting with a ligand-bound second receptor. ALK activation can be abolished through PXL mutation or with PXL-targeting antibodies. Together, these results explain how ALK uses its atypical architecture for its regulation, and suggest new therapeutic opportunities for ALK-expressing cancers such as paediatric neuroblastoma.
Suggested Citation
Tongqing Li & Steven E. Stayrook & Yuko Tsutsui & Jianan Zhang & Yueyue Wang & Hengyi Li & Andrew Proffitt & Stefan G. Krimmer & Mansoor Ahmed & Olivia Belliveau & Ian X. Walker & Krishna C. Mudumbi &, 2021.
"Structural basis for ligand reception by anaplastic lymphoma kinase,"
Nature, Nature, vol. 600(7887), pages 148-152, December.
Handle:
RePEc:nat:nature:v:600:y:2021:i:7887:d:10.1038_s41586-021-04141-7
DOI: 10.1038/s41586-021-04141-7
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:600:y:2021:i:7887:d:10.1038_s41586-021-04141-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.